Bicycle Therapeutics BCYC Cash Flow Statement (2018-2026)

NASDAQ BCYC
$3.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Bicycle Therapeutics Quarterly Cash Flow Statement

Periods 35 quarters
Latest Sep 2026

Bicycle Therapeutics reported cash from operations of -$40.30M and free cash flow of -$40.61M for the quarter ended Sep 2026, up 43.4% year over year. This cash flow statement covers 35 quarters of results from Mar 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-18.04M-27.56M-26.83M-28.35M-29.98M-39.06M-42.60M-49.90M-49.10M-26.56M-39.81M-50.80M-51.85M-60.75M-78.95M-59.10M-20.15M-60.83M-50.33M-10.48M
Depreciation and DepletionDep. & Depletion
0.40M0.40M0.60M1.30M1.50M1.60M1.60M1.70M1.60M1.70M1.60M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.41M0.42M0.62M1.26M1.39M1.56M1.65M1.69M1.65M1.66M1.64M2.17M1.70M1.63M1.70M1.76M1.34M1.13M1.07M1.07M
Share-based CompensationStock Comp.
3.00M10.20M5.67M5.37M5.54M9.04M8.19M7.43M7.81M9.28M9.26M9.20M10.33M9.61M9.44M8.77M11.65M6.93M6.40M5.42M
Deferred Taxes
-0.75M-0.87M-1.02M-2.34M-2.11M-1.58M7.27M-0.28M-0.77M-0.11M-3.32M-1.03M-1.32M-0.33M-0.05M0.84M-0.24M0.33M0.71M
Other non-cash itemsOther Non-Cash
0.12M0.14M0.14M0.09M0.08M0.10M0.10M0.09M0.76M0.10M0.11M1.00M
Change in Working Capital
Change in ReceivablesChange Receivables
1.00M-0.99M10.34M-9.69M1.99M-2.52M-49.84M49.88M0.13M
Change in Account PayablesChange Payables
0.93M-0.26M1.60M3.59M-2.37M-2.00M2.02M3.81M4.17M-5.92M-0.43M-1.24M10.69M-5.02M6.10M-5.07M-2.88M-3.84M-0.06M3.68M
Change in Accrued ExpensesChange Accrued Exp.
1.71M-2.34M5.55M2.29M6.87M-3.13M11.55M-2.33M-3.69M-5.41M1.79M9.58M3.75M-8.21M9.18M1.12M2.00M-2.35M-0.60M-4.73M
Change in Other Operating AssetsOther Assets Change
2.06M3.47M4.46M-4.74M5.84M7.56M-16.17M7.92M2.26M22.57M6.60M3.85M-23.44M11.16M15.96M7.82M-36.61M4.74M5.46M1.67M
Change in Other Operating LiabilitiesOther Liabilities Change
6.17M-3.78M5.39M-3.53M-1.67M-5.77M-11.24M88.71M-6.35M-20.68M-10.24M-3.80M-1.94M-11.02M-4.09M-10.79M-48.75M-1.99M-0.96M-34.30M
Other Working Capital ChangesOther WC Changes
4.11M-7.24M0.93M1.21M-7.51M-13.33M4.94M80.79M-8.61M-43.25M-16.84M-7.65M21.50M-22.18M-20.05M-18.61M-12.14M-6.73M-6.41M-35.98M
Cash from OperationsCash from Ops.
-10.44M-26.40M-23.53M-5.87M-30.31M-46.41M34.10M-1.03M-47.29M-70.87M-44.63M-39.83M-9.40M-86.37M-72.79M-71.17M-19.35M-65.93M-49.61M-40.30M
Investing Activities
Capital ExpendituresCapex
1.07M4.76M9.80M2.98M1.45M2.10M0.28M0.50M0.05M0.01M0.42M0.44M0.37M0.60M0.50M0.67M0.57M0.71M0.27M0.31M
Change in Property, Plant and EquipmentChange in PP&E
-1.07M-4.76M-9.80M-2.98M-1.45M-2.10M-0.28M-0.50M-0.05M-0.01M-0.42M-0.44M-0.37M-0.60M-0.50M-0.67M-0.57M-0.71M-0.27M-0.31M
Cash from Investing ActivitiesCash from Investing
-1.07M-4.76M-9.80M-2.98M-1.45M-2.10M-0.28M-0.50M-0.05M-0.01M-0.42M-0.44M-0.37M-0.60M-0.50M-0.67M-0.57M-0.71M-0.27M-0.31M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.04M0.04M0.05M0.03M0.05M0.07M0.05M0.03M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-0.04M-0.04M-0.05M-0.03M-0.05M-0.07M-0.05M-0.03M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.04M-0.04M-0.05M-0.03M-0.05M-0.07M-0.05M-0.03M
Change in Capital Stock
Common Stock IssuedStock Issued
190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-0.07M0.25M0.00M0.00M0.00M0.03M0.01M0.00M0.00M
Net Shares Issued and RepurchasedNet Shares Issued
190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-0.07M0.25M0.00M0.00M0.00M0.03M0.01M0.00M0.00M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-0.07M0.25M0.00M0.00M0.00M0.03M0.01M0.00M0.00M
Other financing activities (as filed)
Cash from Financing ActivitiesCash from Financing
190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-31.93M0.20M-0.04M-0.05M-0.03M-0.02M-0.05M-0.05M-0.03M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.60M-1.47M-2.60M3.55M0.45M0.51M-0.90M1.29M-0.42M-0.19M1.70M-1.78M0.47M1.81M-1.25M-0.22M-1.94M-0.05M0.51M
Change in Cash
179.16M-31.31M-34.60M-11.30M-22.32M-45.34M46.62M232.20M-45.66M-69.43M504.37M-70.50M-11.34M-86.55M-71.52M-73.13M-20.16M-68.64M-49.97M-40.12M
Ending Cash Balance
438.68M407.37M372.77M361.47M339.15M293.82M340.43M572.63M526.97M457.54M961.91M891.41M880.07M793.52M722.00M648.87M628.72M560.08M510.11M469.99M
Free Cash FlowFCF
-11.50M-31.16M-33.33M-8.86M-31.76M-48.51M33.82M-1.53M-47.34M-70.88M-45.05M-40.27M-9.76M-86.97M-73.28M-71.85M-19.92M-66.64M-49.87M-40.61M
Net Cash FlowNCF
179.16M-30.71M-33.14M-8.70M-25.87M-45.79M46.11M233.10M-46.95M-69.01M504.56M-72.20M-9.56M-87.02M-73.33M-71.88M-19.94M-66.69M-49.92M-40.64M
Interest Paid
0.76M0.66M0.73M0.71M0.69M0.68M0.69M0.69M0.69M0.69M0.46M0.23M0.02M0.02M0.01M0.02M0.03M0.02M0.01M
Income Taxes PaidTaxes Paid
-0.01M-0.04M0.78M0.45M1.03M-0.10M0.23M0.17M-0.26M

Bicycle Therapeutics Cash Flow Statement API

Pull Bicycle Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BCYC&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY